https://doi.org/10.4081/itjm.2021.1377
COVID-19 pneumonia: a tailor-made dress for a Down syndrome patient
Submitted: 27 September 2020
Accepted: 20 October 2020
Published: 18 March 2021
Accepted: 20 October 2020
Abstract Views: 911
PDF: 474
HTML: 17
HTML: 17
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We report here a case of coronavirus disease 2019 pneumonia in a 40-year-old Caucasian woman with Down syndrome admitted to the Internal Medicine Unit. She was initially treated with hydroxychloroquine and azithromycin. When respiratory conditions dramatically worsened, she was not admitted to the intensive care unit because of impaired cognitive function. Thus helmet-based continuous positive airway pressure was started. The respiratory conditions progressively improved, reaching spontaneous breathing.
Meo SA, Klonoff DC, Akram J. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci 2020;24:4539-47.
Chen D, Li X, Song Q, et al. Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Netw Open 2020;3(6) [Epub ahead of print].
DOI: https://doi.org/10.1001/jamanetworkopen.2020.11122
Toniati P, Piva S, Cattalini M, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev 2020;19(7) [Epub ahead of print].
Ing RJ, Corey B, Glenn M, et al. Role of helmet-delivered noninvasive pressure support ventilation in COVID-19 patients. J Cardiothorac Vasc Anesth 2020 May 8 [Epub ahead of print].
DOI: https://doi.org/10.1053/j.jvca.2020.04.060
Liu Q, Gao Y, Chen R. Noninvasive ventilation with helmet versus control strategy in patients with acute respiratory failure: A systematic review and meta-analysis of controlled studies. Crit Care 2016;20:265.
DOI: https://doi.org/10.1186/s13054-016-1449-4
Taccone P, Hess D, Caironi P, Bigatello LM. Continuous positive airway pressure delivered with a "helmet": effects on carbon dioxide rebreathing. Crit Care Med 2004;32:2090-6.
DOI: https://doi.org/10.1097/01.CCM.0000142577.63316.C0
Joffe, Lesage F, Bustarret O, et al. Children with Down syndrome: clinical course and mortality-associated factors in a French medical pediatric intensive care unit. J Pediatr Child Health 2016;52:595-9.
DOI: https://doi.org/10.1111/jpc.13214
Robert R, Le Gouge A, Kentish-Barnes N, et al. Sedation practice and discomfort during withdrawal of mechanical ventilation in critically ill patients at end-of-life: a post-hoc analysis of a multicenter study. Intensive Care Med 2020;46:1194-203.
DOI: https://doi.org/10.1007/s00134-020-05930-w
Pattinson KT. Opioids and the control of respiration. Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers. Br J Anaesth 2008;100:747-58.
Rello J, Storti E, Belliato M, Serrano R. Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers. Eur Respir J 2020;55(5) [Epub ahead of print].
DOI: https://doi.org/10.1183/13993003.01028-2020
How to Cite
Uggeri, S., Gilioli, F., Cosenza, R., Nasi, F., Moreali, S., & Guicciardi, N. (2021). COVID-19 pneumonia: a tailor-made dress for a Down syndrome patient. Italian Journal of Medicine, 15(1). https://doi.org/10.4081/itjm.2021.1377
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
List of Cited By :
